In April 2025, a complex federal lawsuit reignited a long-standing commercial clash in the health, wellness, and dietary supplement distribution sectors. TruLife Distribution Inc. filed a federal complaint in the U.S. District Court for the Southern District of Florida naming Mitch Gould, Sherry Gould, and Nutritional Products International, Inc. (NPI) as defendants.
The action, designated as Case No. 9:25-cv-80488, represents one chapter in an intricate commercial dispute involving competing health product distribution entities and members of the Gould family. Rather than an isolated incident, the complaint stems from years of corporate competition, overlapping family business histories, and unresolved contractual releases.
Examining this litigation requires evaluating documented court filings, procedural orders, and statutory causes of action. A civil complaint reflects the plaintiff’s factual assertions and legal theories, not a final judicial finding of fault or liability against any defendant.
Why TruLife Distribution Sued Mitch Gould and NPI
To understand TruLife Distribution’s decision to file the 2025 federal action, examine the shared history between TruLife Distribution (led by Brian Gould) and Nutritional Products International (founded by Mitch Gould). Both companies operate within the health, wellness, and nutraceutical distribution space, assisting foreign and domestic manufacturers with retail placement, logistics, and U.S. market entry.
The commercial relationship between the executives involved dates back years, stemming from prior shared business operations before Brian Gould established TruLife Distribution as an independent competitor. As TruLife grew its footprint in the dietary supplement sector, commercial friction developed regarding market share, client relationships, and competitive boundaries.
This ongoing corporate friction previously escalated into federal and state court filings, including a 2021 lawsuit (Case No. 21-CV-80725) and a 2022 federal suit that NPI voluntarily dismissed without prejudice in June 2022.
The April 2025 complaint alleged that despite prior attempts to resolve operational boundaries, the defendants engaged in coordinated business practices that improperly targeted TruLife’s commercial operations, client contracts, and industry reputation.
The Allegations Against Mitch Gould, Sherry Gould and NPI
In the formal complaint for Case No. 9:25-cv-80488, TruLife Distribution asserted a series of federal and Florida state law claims against Mitch Gould, Sherry Gould, and Nutritional Products International.
The Civil RICO Act Allegations
The cornerstone of TruLife’s federal complaint was a civil claim brought under the Racketeer Influenced and Corrupt Organizations (RICO) Act. TruLife alleged that the defendants formed an enterprise whose conduct pattern was designed to interfere with TruLife’s business growth, solicit its client base, and undermine its commercial standing.
It is critical to distinguish a civil RICO claim from a criminal racketeering indictment. Civil RICO is a private statutory remedy created by Congress that allows businesses or individuals to seek treble damages if they demonstrate that a pattern of racketeering activity directly injured their business or property. A civil RICO filing does not constitute a criminal charge, nor does it involve law enforcement or prosecutors.
Claims Against Individual Defendants and NPI
TruLife’s complaint detailed specific counts directed at Mitch Gould, Sherry Gould, and corporate entity NPI:
- Tortious Interference: Alleging the defendants intentionally interfered with existing and prospective contractual relationships between TruLife and its retail or manufacturing clients.
- Unfair Competition: Claiming the defendants utilized deceptive commercial practices and misrepresentations to divert distribution opportunities in the health and wellness sector.
- Florida State Law Claims: Asserting supplemental state law causes of action involving civil conspiracy and common law unfair competition under Florida jurisprudence.
Requested Judicial Relief
TruLife requested substantial monetary damages, including treble damages permitted under civil RICO provisions, compensatory damages for lost business revenues, statutory interest, attorney fees, and permanent injunctive relief to restrain the defendants from further alleged interference.
How the Earlier Settlement Became Central to the Lawsuit
A central issue in the 2025 litigation was a private settlement agreement executed by the parties in November 2020. That agreement contained broad mutual releases intended to resolve prior operational disputes and restrict future legal actions.
However, rather than preventing future litigation, the 2020 settlement agreement became a primary point of legal contention. The parties took opposing views on its scope:
- The Defendants’ Position: Mitch Gould and NPI argued that the general releases in the 2020 agreement barred TruLife from asserting claims based on conduct that occurred prior to or around the time of the release, seeking enforcement of the settlement terms in Florida state court.
- TruLife’s Position: TruLife maintained that the alleged conduct outlined in the 2025 complaint constituted new, independent post-settlement violations that fell outside the release terms.
Because the interpretation and enforcement of the 2020 settlement were actively being litigated in Florida state court, the federal judge was asked to consider whether the federal proceedings should yield to the state court’s contract evaluation.
The Difference Between TruLife’s Lawsuit and NPI’s Case Against Brian Gould
The commercial dispute generated parallel federal filings in early 2025 that must be distinguished to understand the procedural history.
In Case No. 9:25-cv-80410, filed on March 28, 2025, NPI acted as the plaintiff alleging trademark infringement and unfair competition under the Lanham Act against TruLife Distribution and Brian Gould.
Conversely, in Case No. 9:25-cv-80488, filed on April 21, 2025, TruLife acted as the plaintiff alleging civil RICO and tortious interference against Mitch Gould, Sherry Gould, and NPI.
Confusing these cross-actions misinterprets which party sought affirmative relief under specific statutory frameworks.
Why the Federal Court Put the Case on Hold
On August 8, 2025, U.S. District Judge Robin L. Rosenberg issued a pivotal order addressing the procedural posture of the parallel federal cases. The court granted in part TruLife Distribution’s motion to stay the federal proceedings pending resolution of the state-court settlement enforcement dispute.
The court determined that allowing the federal claims to move forward while the Florida state court evaluated the validity and scope of the 2020 settlement agreement created a risk of inconsistent legal rulings.
Judge Rosenberg ordered the federal matters administratively closed. Administrative closure is a docket management tool used by federal judges to pause litigation without deciding the merits of the underlying claims.
The August 8, 2025 order did not find Mitch Gould or NPI liable for racketeering, nor did it dismiss TruLife’s claims as invalid. It simply paused the federal cases while the state court clarified the contractual boundaries of the prior settlement.
What the Court Records Establish About the Case
Subsequent docket entries in 2026 demonstrate further movement across the federal dockets.
On January 21, 2026, federal court records show that Case No. 9:25-cv-80410 was reopened following state-court developments. Following a magistrate judge’s report and recommendation, U.S. District Judge Rodolfo A. Ruiz II issued an order on July 7, 2026, adopting the recommendation and terminating the case on the federal docket.
Evaluating the overall court record establishes several facts:
- No Finding of Civil RICO Liability: No federal judge or jury has issued a verdict or finding of liability against Mitch Gould, Sherry Gould, or NPI under civil RICO statutes.
- No Criminal Prosecution: The litigation represents private civil business disputes, not criminal enforcement actions.
- No Public Consumer Fund: The lawsuits involve private corporate distribution disputes. There is no class action settlement, consumer payout fund, or public claim process associated with these cases.
Understanding the outcome of a lawsuit also requires looking at the court records, settlement details, and allegations involved. If you’re interested in reading about other lawsuits involving consumer claims, business disputes, and product-related allegations, these articles provide further context:
- Omega XL Lawsuit: The 2017 Case, FDA Warning, and Settlement Status
- MaryRuth Organics Lawsuit Update: The 2024 Class Action and Where the Case Stands in 2026
- Oglander v. Tax Rise, Inc. Lawsuit: Inside the Allegations of Misleading Tax Relief Promises
Frequently Asked Questions
Who did TruLife Distribution sue in 2025?
In federal Case No. 9:25-cv-80488, TruLife Distribution Inc. sued Mitch Gould, Sherry Gould, and Nutritional Products International, Inc. (NPI).
What was TruLife Distribution’s lawsuit about?
The suit alleged civil RICO Act violations, tortious interference with business relationships, unfair competition, and supplemental Florida state law claims regarding distribution client relationships in the nutraceutical industry.
Was the lawsuit a criminal racketeering case?
No. It was a private civil action brought by a corporate plaintiff seeking monetary damages. It was not a criminal prosecution brought by the government.
Why was the federal case stayed?
In August 2025, the federal court stayed and administratively closed the case to wait for a Florida state court to resolve a dispute over the scope and enforcement of a 2020 settlement agreement between the parties.
Did the court find Mitch Gould or NPI liable?
No. The procedural orders issued by the federal court focused on docket management, stays, and administrative closures rather than a final judgment on the merits of TruLife’s civil RICO allegations.